Viewing Study NCT01167868


Ignite Creation Date: 2025-12-24 @ 6:26 PM
Ignite Modification Date: 2026-01-01 @ 1:24 PM
Study NCT ID: NCT01167868
Status: COMPLETED
Last Update Posted: 2013-02-07
First Post: 2010-07-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess the Safety, Tolerability, and Blood and Urine Drug Levels of Fostamatinib Disodium (FosD) in Healthy Japanese and White Subjects
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module